AzTrials
AzTrials

Bowel PreparationNCT06000241

Comparison of Same Morning vs Previous Evening Dosing Regimen for Assessment of Quality of Bowel Preparation for Colonoscopy Under Anesthesia

An observational study of Bowel Preparation, run by Peking Union Medical College Hospital at 2 sites in China.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

220 patients are allocated randomly to the morning group (am group) or the afternoon group (pm group) and assessed by quality of bowel preparation and residual volume gastric residue. Read more about this study

Who is it for?
Ages 18 to 80 years
Conditions the study is for
Bowel Preparation
How many people
220 participants
Where
2 sitesChina
Study dates
1 Jan 2021to 1 Jul 2023
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 80 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: Participants have a cluster of elective EGD and colonoscopy under anesthesia.

Who may be able to join

  • Patients are able to follow the instructions of bowel preparation and have good ability of walking at least an hour.

Who cannot join

  • Clinical diagnosis of obstruction of bowel and sever renal and heart disease.

Trial locations and contacts

2 sites in 1 country.

China2 sites
  • Peking Union Medical Hospital

    Beijing, Beijing Municipality, 100730

  • Peking Union Medical College Hospital

    Beijing

Other trials in China

About this study

Official title: Comparison of Same Morning vs Previous Evening Dosing Regimen for Assessment of Quality of Bowel Preparation Under Anesthesia

220 patients are allocated randomly to the morning group (am group) or the afternoon group (pm group) and assessed by quality of bowel preparation and residual volume gastric residue.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. ottawa score

    Two nurses observe cleaning of three parts of colon and give a score for each.

    Measured: a day

  2. gastric residual volume

    Gastric contents are suctioned and measured.

    Measured: 30 minutes

  3. colonic residual volume

    Colonic fluids are suctioned and measured.

    Measured: 30 minutes

Secondary outcomes (2)
  1. reflux

    incidence of reflux during both the EGD and colonoscopy

    Measured: 60mins

  2. adenoma detection rate

    percentages of patients screened with colonic adenoma in total patients

    Measured: a day

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted21 Aug 2023
  2. Study start1 Jan 2021
  3. Primary completion15 Jun 2023
  4. Study completion1 Jul 2023

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case only
Time perspective
Cross-sectional
Enrolment
220 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06000241
Sponsor's protocol ID
JS-3388
Status last verified
Mar 2023
First submitted
14 Aug 2023
Last updated
21 Aug 2023
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

An observational study of Bowel Preparation, run by Peking Union Medical College Hospital at 2 sites in China.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 21 Aug 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in China. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

ottawa score (time frame: a day). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 21 Aug 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in